Brief: 23AndMe Therapeutics Announces Phase 2 Results For Two Additional Cancer Cohorts And Correlative Biomarker Data From 23Me-00610 Study

Chrome Holding Co

15/09/2024 08:07

Sept 15 (Reuters) - 23andMe Holding Co.  ME.O :
    * 23ANDME THERAPEUTICS ANNOUNCES PHASE 2 RESULTS FOR TWO
ADDITIONAL CANCER COHORTS AND CORRELATIVE BIOMARKER DATA FROM
23ME-00610 STUDY
    * 23ANDME HOLDING CO.  - GREATER RESPONSE IN "COLD" TUMORS
SUGGESTS OPPORTUNITY IN PATIENTS UNABLE TO BENEFIT FROM
PD-1/PD-L1 CHECKPOINT INHIBITORS

Source text for Eikon:  ID:nGNX8y1mvc 
Further company coverage:  ME.O 

 ((Reuters.Briefs@thomsonreuters.com;))